DSpace

DSpace at RU >

Browsing by Author Wering, E.R. van

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 13 of 13
Full TextIssue DateTitleAuthor(s)
2010Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol.Velden, V.H. van der; Sluijs-Geling, A. van der; Gibson, B.E.; Marvelde, J.G. Te; Hoogeveen, P.G., et al
2010Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.Balgobind, B.V.; Hollink, I.H.; Reinhardt, D.; Wering, E.R. van; Graaf, S.S.N. de, et al
2010EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.Balgobind, B.V.; Lugthart, S.; Hollink, I.H.; Arentsen-Peters, S.T.; Wering, E.R. van, et al
2009Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).Veerman, A.J.P.; Kamps, W.A.; Berg, H. van den; Berg, E. van den; Bokkerink, J.P.M., et al
2006Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.Loo, D.M.W.M. te; Kamps, W.A.; Berg, A. van den; Wering, E.R. van; Graaf, S.S.N. de
2006Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects.Brouwer, C.; Vermunt-de Koning, D.G.M.; Trueworthy, R.C.; Riet, P.G.J.H. ter; Duley, J.A., et al
2005Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.Kardos, G.; Zwaan, C.M.; Kaspers, G.J.L.; Graaf, S.S.N. de; Bont, E.S. de, et al
2005Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.Brouwer, C.; Vogels-Mentink, T.M.; Keizer-Garritsen, J.J.; Trijbels, J.M.F.; Bökkerink, J.P.M., et al
2005Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.Brouwer, C.; Abreu, R.A. de; Keizer-Garritsen, J.J.; Lambooy, L.H.J.; Ament, K., et al
2004Three-colour flowcytometric analysis of mature and immature hematological malignancies : A guideline of the Dutch Foundation for Immunophyenotyping of Hematological Malignancies (SIHON)Wering, E.R. van; Lochem, E.G. van; Leenders, M.; Sluijs-Gelling, A.J. van der; Wind, H., et al
1996Het alveolaire rabdomyosarcoom met leukemische presentatieEnsink, R.J.H.; Vaan, G.A.M. de; Wering, E.R. van
1996Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemiaKaspers, G.J.L.; Veerman, A.J.P.; Popp-Snijders, C.; Lomecky, M.; Zantwijk, C.H. van, et al
1996High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.Veerman, A.J.P.; Hählen, K.; Kamps, W.A.; Leeuwen, E.F. van; Vaan, G.A.M. de, et al
Showing results 1 to 13 of 13

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback